Skip to main content

Table 1 Large spectrum of hypertension and diabetes patient population selected for the multicenter study that will evaluate the efficacy and tolerability of monotherapy and double and triple-antlhy pertensive combination therapies

From: A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]

GoalBP*

Threshold

Upper limit

for all patients regardless BP values

for initiation of double-combination

of BP values targeted

< 130/80 mmHg

> 150/90 mmHg

≤ 179/109 mmHg

  1. * The Goal BP defines the cut off point for responders/non-responders to any therapy.